Sreedhar Subramanian

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Nicholas Kennedy

Honorary Clinical Senior Lecturer

University of Exeter

UNITED KINGDOM

View details

James Lindsay

Professor of Inflammatory Bowel Disease.

Queen Mary University of London

UNITED KINGDOM

View details

Shaji Sebastian

UNITED KINGDOM

View details

Gordon Moran

University of Nottingham

UNITED KINGDOM

View details

Joanne K Taylor

The University of Manchester

UNITED KINGDOM

View details

Andrew Spence

The Queen's University Belfast

UNITED KINGDOM

View details

Martin Hewison

University of Birmingham

UNITED KINGDOM

View details

Neeraj Bhala

Clinical Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Simon P L Travis

UNITED KINGDOM

View details

Matthew Brookes

Professor

University of Wolverhampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sreedhar Subramanian

Research Interests

Explore related searches

Contact this professor

Articles (13)

Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn’s Disease Patients

Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: Insights from a multicentre UK cohort study

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study

Establishment of a validated central reading system for ileocolonoscopy in an academic setting

Vitamin D, vitamin D—binding protein, free vitamin D and COVID-19 mortality in hospitalized patients

Editorial: intravenous to subcutaneous vedolizumab—switch without glitch!

Recurrent colonic polyps

Letter: risk of severe COVID‐19 outcomes associated with inflammatory bowel disease medications—reassuring insights from the United Kingdom PREPARE‐IBD multicentre cohort study

Unexpected cause of dysphagia

Editorial: vedolizumab in inflammatory bowel diseases—less is more?

Letter: propensity score—handle with care. Authors’ reply

Collaborators (10)

Nicholas Kennedy

James Lindsay

Shaji Sebastian

Gordon Moran

Joanne K Taylor

Andrew Spence

Martin Hewison

Neeraj Bhala

Simon P L Travis

Matthew Brookes

Make your next move.